Ulcerative Colitis and Its Treatment with Mesenchymal Stem Cell Therapy

 

Ulcerative Colitis is a painful and chronic bowel disease that causes significant suffering for patients. It results in an inflammatory reaction, causing severe pain and digestive problems. This disease can impair nutrient absorption, weaken a person, and rapidly lower their immunity.

The inflammatory reactions caused by the disease manifest as ulceration, injury, bleeding, swelling, irritation, and other effects that significantly impact the patient's well-being. Ulcerative Colitis is characterized by ulcers in the mucosa lining of the colon.

The most common types of inflammatory bowel diseases are Ulcerative Colitis and Crohn's Disease. Ulcerative Colitis primarily affects the large intestine, resulting in ulcer-like effects visible in the colon.

Symptoms and Complications

The disease can cause severe bleeding from deep ulcerated areas, intestinal perforation, and dilation of the intestinal tract. This condition is known as toxic dilatation or toxic megacolon, which are prominent symptoms of the disease.

In addition to affecting the colon and digestive tract, this disease can potentially affect distant organs. Symptoms can include fever, severe weight loss, decreased appetite, weakness, and others.

Ulcerative Colitis can also cause inflammation in joints, such as those in the pelvis and spine. Therefore, bone and joint health should be carefully managed in such cases.

This disease can manifest symptoms on the skin, such as red swelling. Inflammation of the eye due to colitis is known as uveitis. Inflammatory reactions can also develop in the biliary tract and liver.

Stem Cell Therapy for Ulcerative Colitis

Stem Cell Therapy is a significant innovation in medical science currently used to treat various chronic diseases, with potential benefits in cancer regression or complete remission. Due to its wide application in treating autoimmune disorders, it is currently used in the treatment of Ulcerative Colitis. Mesenchymal Stem Cell Therapy, a component of treatment for Ulcerative Colitis, can potentially reduce or halt the disease, promoting better health and longevity. Typically, the success rate of the treatment correlates with the patient's age. However, elderly patients have also shown positive responses to the treatment.

Appropriate treatment and systematic measures can potentially lead to complete disease remission. At Biotherapy International, the treatment involves harvesting stem cells from the patient's own body, which are then used in the therapy. If those are not accessible, MSCs from the placenta and cord tissue of unrelated donors can also be used.